CareLit · DOI-Nachweis · Pneumologie
Multicenter phase II study evaluating Dxl/Cis as induction regimen prior to surgery or radiochemotherapy in stage II-IIIB NSCLC patients (TAX-AT 1.203)
DOI 10.1055/s-0034-1375925
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Kocher, A Pircher, A Mohn-Staudner, F Romeder, W Duller, M Steinmaurer, J Eckmayr, T Schmid, W Hilbe, M Fiegl, R Greil
ZeitschriftPneumologie
Ausgabe05/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objectives: Neoadjuvant therapy with a platinum based doublet is an option in NSCLC with upfront resectable disease. However, the role of neoadjuvant induction in stages IIIA and IIIB and in initially not resectable patients is unclear. Patients and Methods: In this phase II trial, 78 patients with locally advanced NSCLC, of whom 56 were considered not resectable at initial diagnosis, were treated with three neoadju…
Zitieren
Zitierempfehlung
F Kocher, A Pircher, A Mohn-Staudner, F Romeder, W Duller, M Steinmaurer, J Eckmayr, T Schmid, W Hilbe, M Fiegl, R Greil (2014) Multicenter phase II study evaluating Dxl/Cis as induction regimen prior to surgery or radiochemotherapy in stage II-IIIB NSCLC patients (TAX-AT 1.203). Pneumologie (05). https://doi.org/10.1055/s-0034-1375925
Mit CareLit weiterarbeiten